These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 20870161
21. Novel Pyrazolo[1,5-a]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, in Vitro Biological Evaluation, [(18)F]-Labeling, and in Vivo Neuroinflammation PET Images. Damont A, Médran-Navarrete V, Cacheux F, Kuhnast B, Pottier G, Bernards N, Marguet F, Puech F, Boisgard R, Dollé F. J Med Chem; 2015 Sep 24; 58(18):7449-64. PubMed ID: 26280386 [Abstract] [Full Text] [Related]
23. [18F]FEAC and [18F]FEDAC: Two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain. Yanamoto K, Kumata K, Yamasaki T, Odawara C, Kawamura K, Yui J, Hatori A, Suzuki K, Zhang MR. Bioorg Med Chem Lett; 2009 Mar 15; 19(6):1707-10. PubMed ID: 19217778 [Abstract] [Full Text] [Related]
24. Evaluation of PET Imaging Performance of the TSPO Radioligand [18F]DPA-714 in Mouse and Rat Models of Cancer and Inflammation. Zheng J, Winkeler A, Peyronneau MA, Dollé F, Boisgard R. Mol Imaging Biol; 2016 Feb 15; 18(1):127-34. PubMed ID: 26194010 [Abstract] [Full Text] [Related]
26. Efficient radiosynthesis and non-clinical safety tests of the TSPO radioprobe [(18)F]FEDAC: Prerequisites for clinical application. Kawamura K, Kumata K, Takei M, Furutsuka K, Hashimoto H, Ito T, Shiomi S, Fujishiro T, Watanabe R, Igarashi N, Muto M, Yamasaki T, Yui J, Xie L, Hatori A, Zhang Y, Nemoto K, Fujibayashi Y, Zhang MR. Nucl Med Biol; 2016 Jul 15; 43(7):445-53. PubMed ID: 27183465 [Abstract] [Full Text] [Related]
27. Synthesis of two novel [18F]fluorobenzene-containing radiotracers via spirocyclic iodonium ylides and positron emission tomography imaging of translocator protein (18 kDa) in ischemic brain. Fujinaga M, Kumata K, Zhang Y, Hatori A, Yamasaki T, Mori W, Ohkubo T, Xie L, Nengaki N, Zhang MR. Org Biomol Chem; 2018 Sep 26; 16(37):8325-8335. PubMed ID: 30206613 [Abstract] [Full Text] [Related]
28. Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline. Buck JR, McKinley ET, Hight MR, Fu A, Tang D, Smith RA, Tantawy MN, Peterson TE, Colvin D, Ansari MS, Baldwin RM, Zhao P, Guleryuz S, Manning HC. J Nucl Med; 2011 Jan 26; 52(1):107-14. PubMed ID: 21149488 [Abstract] [Full Text] [Related]
29. In vivo measurement of the affinity and density of metabotropic glutamate receptor subtype 1 in rat brain using 18F-FITM in small-animal PET. Yamasaki T, Fujinaga M, Kawamura K, Yui J, Hatori A, Ohya T, Xie L, Wakizaka H, Yoshida Y, Fukumura T, Zhang MR. J Nucl Med; 2012 Oct 26; 53(10):1601-7. PubMed ID: 22915159 [Abstract] [Full Text] [Related]
30. Evaluation of TSPO PET Ligands [18F]VUIIS1009A and [18F]VUIIS1009B: Tracers for Cancer Imaging. Tang D, Li J, Buck JR, Tantawy MN, Xia Y, Harp JM, Nickels ML, Meiler J, Manning HC. Mol Imaging Biol; 2017 Aug 26; 19(4):578-588. PubMed ID: 27853987 [Abstract] [Full Text] [Related]
31. In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [(18)F]GE-180 and effect of docosahexaenoic acid. Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Vadivelu KC, Yip PK, Sosabowski J, Trigg W, Michael-Titus AT. Eur J Nucl Med Mol Imaging; 2016 Aug 26; 43(9):1710-22. PubMed ID: 27154521 [Abstract] [Full Text] [Related]
32. Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18F]Fluoroethoxy)phenyl)-5-Methylpyrazolo[1,5-a]Pyrimidin-3-yl)-N,N-Diethylacetamide (18F-VUIIS1018A) to Image Glioma. Tang D, Li J, Nickels ML, Huang G, Cohen AS, Manning HC. Mol Imaging Biol; 2019 Feb 26; 21(1):113-121. PubMed ID: 29869061 [Abstract] [Full Text] [Related]
35. The translocator protein radioligand 18F-DPA-714 monitors antitumor effect of erufosine in a rat 9L intracranial glioma model. Awde AR, Boisgard R, Thézé B, Dubois A, Zheng J, Dollé F, Jacobs AH, Tavitian B, Winkeler A. J Nucl Med; 2013 Dec 26; 54(12):2125-31. PubMed ID: 24212976 [Abstract] [Full Text] [Related]
36. Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain. Zhang MR, Maeda J, Ogawa M, Noguchi J, Ito T, Yoshida Y, Okauchi T, Obayashi S, Suhara T, Suzuki K. J Med Chem; 2004 Apr 22; 47(9):2228-35. PubMed ID: 15084121 [Abstract] [Full Text] [Related]
37. Imaging of peripheral-type benzodiazepine receptor in tumor: in vitro binding and in vivo biodistribution of N-benzyl-N-[(11)C]methyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide. Yamasaki T, Kumata K, Yanamoto K, Hatori A, Takei M, Nakamura Y, Koike S, Ando K, Suzuki K, Zhang MR. Nucl Med Biol; 2009 Oct 22; 36(7):801-9. PubMed ID: 19720292 [Abstract] [Full Text] [Related]
40. Radiosynthesis and characterization of [18F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism. Lee SH, Denora N, Laquintana V, Mangiatordi GF, Lopedota A, Lopalco A, Cutrignelli A, Franco M, Delre P, Song IH, Kim HW, Kim SB, Park HS, Kim K, Lee SY, Youn H, Lee BC, Kim SE. Eur J Nucl Med Mol Imaging; 2021 Dec 22; 49(1):110-124. PubMed ID: 34783879 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]